Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ploytuangporn Wongchanapai"'
Autor:
Julanee Leenanitikul, Prangwalai Chanchaem, Suwanan Mankhong, Sikrit Denariyakoon, Valla Fongchaiya, Areeya Arayataweegool, Pattama Angspatt, Ploytuangporn Wongchanapai, Verayuth Prapanpoj, Kris Chatamra, Trairak Pisitkun, Sira Sriswasdi, Piriya Wongkongkathep
Publikováno v:
PLoS ONE, Vol 18, Iss 10, p e0292879 (2023)
Next generation sequencing of circulating tumor DNA (ctDNA) has been used as a noninvasive alternative for cancer diagnosis and characterization of tumor mutational landscape. However, low ctDNA fraction and other factors can limit the ability of ctD
Externí odkaz:
https://doaj.org/article/61f435fb469d4432b621fddb99e6faeb
Autor:
Chawanya Rabiltossaporn, Ploytuangporn Wongchanapai, Nattaya Poovoravan, Piyada Sitthideatphaiboon, Virote Sriuranpong, Suebpong Tanasanvimon
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 22(12)
Complementary and Alternative Medicine (CAM) is widely used among cancer patients worldwide. This prospective observational study aimed to show the effect of CAM use on chemotherapy delivery in Thai patients.During March 2014 to February 2015, the pa
Autor:
Chanida Vinayanuwatikun, Ploytuangporn Wongchanapai, Wilai Thawinwisan, Napa Parinyanitikun, Piyachut Chenaksara, Suebpong Tanasanvimon, Virote Sriuranpong, Siwat Sakdejayont, Nattaya Poovorawan, Pattama Angspatt, Shama Sukprakun, Veerisa Vimolchalao
Publikováno v:
International journal of clinical oncology. 25(2)
To evaluate the efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for chemotherapy-induced nausea vomiting (CINV) prevention in patients receiving highly emetogenic chemotherapy (HEC). In this randomized, double-blind
Autor:
Nattaya Sintawichai, Suleepon Uttamapinan, Veerisa Vimolchalao, Chanida Vinayanuwattikun, Ploytuangporn Wongchanapai, Siwat Sakdejayont, Sutima Luangdilok, Virote Sriuranpong, Nattaya Poovorawan, Napa Parinyanitikul, Suebpong Tanasanvimon, Shama Sukprakun
Publikováno v:
Journal of Clinical Oncology. 36:10019-10019
10019Background: Currently, the antiemetic regimen consisting of dexamethasone, palonosetron plus a NK-1 antagonist or olanzapine is recommended in prevention of chemotherapy induced nausea and vom...